Search hospitals > Kentucky > Louisville

Norton Cancer Institute

Claim this profile
Louisville, Kentucky 40202
Global Leader in Lymphoma
Global Leader in Cancer
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Lung Cancer
Conducts research for Leukemia
220 reported clinical trials
13 medical researchers
Photo of Norton Cancer Institute in LouisvillePhoto of Norton Cancer Institute in LouisvillePhoto of Norton Cancer Institute in Louisville

Summary

Norton Cancer Institute is a medical facility located in Louisville, Kentucky. This center is recognized for care of Lymphoma, Cancer, Non-Small Cell Lung Cancer, Lung Cancer, Leukemia and other specialties. Norton Cancer Institute is involved with conducting 220 clinical trials across 174 conditions. There are 13 research doctors associated with this hospital, such as John Hamm, MD, Don Stevens, MD, Jaspreet Grewal, MD, and Joseph Maly.

Area of expertise

1Lymphoma
Global Leader
Norton Cancer Institute has run 39 trials for Lymphoma. Some of their research focus areas include:
MYC positive
BCL2 positive
BCL6 positive
2Cancer
Global Leader
Norton Cancer Institute has run 38 trials for Cancer. Some of their research focus areas include:
Stage IV
Stage III
PD-L1 positive

Top PIs

Clinical Trials running at Norton Cancer Institute

Non-Hodgkin's Lymphoma
Lymphoma
B-Cell Lymphoma
Cancer
Non-Small Cell Lung Cancer
Squamous Cell Carcinoma
Oral Squamous Cell Carcinoma
Colorectal Cancer
Head and Neck Cancers
Peripheral T-Cell Lymphoma
Image of trial facility.

1A46 Injection

for Non-Hodgkin's Lymphoma and Acute Lymphoblastic Leukemia

This study will evaluate the safety and efficacy of 1A46 in adult patients with advanced CD20 and/or CD19 positive B-cell non-Hodgkin's lymphoma (NHL) or acute lymphoblastic leukemia (ALL).
Recruiting1 award Phase 1 & 2
Image of trial facility.

REGN5837 + Odronextamab

for Aggressive B-Cell Lymphoma

The study is researching an experimental drug called REGN5837 in combination with another experimental drug, odronextamab. The aim of the study is to see how safe and tolerable the study drugs are, and to define the recommended dose for phase 2 for the combination. The study is focused on patients with relapsed or refractory aggressive B-cell non-Hodgkin lymphomas (B-NHLs). The study is looking at several other research questions, including: What side effects may happen from taking the study drugs How much study drug is in your blood at different times Whether the body makes antibodies against the study drugs (that could make the drugs less effective or could lead to side effects) To find out how well the study drugs work against relapsed or refractory aggressive B-cell non-Hodgkin lymphomas (B-NHLs)
Recruiting1 award Phase 1
Image of trial facility.

Nanatinostat + Valganciclovir

for EBV-Positive Lymphoma

This study is evaluating whether a drug called nanatinostat can be used to treat people with EBV-positive lymphomas.
Recruiting1 award Phase 2

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at Norton Cancer Institute?
Norton Cancer Institute is a medical facility located in Louisville, Kentucky. This center is recognized for care of Lymphoma, Cancer, Non-Small Cell Lung Cancer, Lung Cancer, Leukemia and other specialties. Norton Cancer Institute is involved with conducting 220 clinical trials across 174 conditions. There are 13 research doctors associated with this hospital, such as John Hamm, MD, Don Stevens, MD, Jaspreet Grewal, MD, and Joseph Maly.